Hello, Guest
Login
Sign Up
 
 

News Buzz: Impax Laboratories Inc, Legacy Reserves LP, Mercadolibre Inc, Mindray Medical International Ltd

 
 
Repost This

Lakeway, NY -- (SBWIRE) -- 02/26/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Impax Laboratories Inc. (NASDAQ:IPXL) closed at $19.62. The Company reported fourth quarter 2012 adjusted net income of $20.5 million or $0.30 per diluted share compared to $21.9 million or $0.33 per diluted share in the fourth quarter 2011. For the fourth quarter 2012, total revenues were $141.1 million, a decrease of 11%, compared to $158.6 million in the prior year period, primarily due to lower sales of the Company's authorized generic Adderall XR® products as a result of additional competition.

Get Latest News, Updates on IPXL Here

Legacy Reserves LP (NASDAQ:LGCY) closed at $25.92. The Company reported fourth quarter EPS of $0.04, below the analyst estimate of $0.37. Revenue for the quarter was $90.46 million versus the consensus estimate of $89.98 million. Production increased by 6% to 15,729 Boe/d compared to 14,772 Boe/d in the prior quarter primarily due to recent acquisitions.The average realized prices, excluding commodity derivatives settlements, were $62.51 per Boe in the fourth quarter.

Is LGCY a Strong Buying Opportunity After The Recent Slump? Find out Here

Mercadolibre Inc. (NASDAQ:MELI) increased 1.70% to $86.0 after market trading hours. The Company reported fourth quarter EPS of $0.69, up from $0.47 last year. Net revenues came in at $103.8 million. The consensus estimates were for EPS of $0.61 and revenues of $105.27 million.

Is MELI Signaling a Buy After The Sudden Gain? Don’t Miss Out Free Trend Analysis Here

Mindray Medical International Ltd (ADR) (NYSE:MR) closed at $36.67. The company announced fourth quarter results. The net revenues increased 19.7% to $316.1 million for the fourth quarter of 2012. The gross profit was $182.8 million, a 27.7% increase from $143.1 million in the fourth quarter of 2011. Operating income in the fourth quarter was $59.7 million, a 24.6% increase from $47.9 million in the fourth quarter of 2011. The net income increased 19.3% to $55.8 million.

Get latest News, Updates on MR Here

About ThePennyStockProfiler.com
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.ThePennyStockProfiler.com

Disclaimer
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.